- $9.43bn
- $8.88bn
- $642.82m
U.S. STOCKS ON THE MOVE-Walt Disney, Mattel, Tellurian
U.S. STOCKS ON THE MOVE-Verizon Communications, Reddit, Starbucks
U.S. STOCKS ON THE MOVE-Cassava Sciences, Crowdstrike Holdings, crypto stocks
U.S. STOCKS ON THE MOVE-Bank of America, Nvidia, Serve Robotics
10x Genomics advances after Jefferies upgrades to 'buy'
U.S. RESEARCH ROUNDUP-BlackRock, Goldman Sachs, Netflix
U.S. RESEARCH ROUNDUP-Corecivic, Eli Lilly, Wd-40
10X Genomics Inc reports results for the quarter ended in March - Earnings Summary
Brief: 10X Genomics Q1 Revenue USD 141 Million Vs. IBES Estimate USD 142.2 Million
U.S. RESEARCH ROUNDUP- Avalonbay Communities, General Dynamics, Tyler Technologies
10X Genomics Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
Brief: 10X Genomics Begins Commercial Shipments Of Chromium Gem-X Products
U.S. RESEARCH ROUNDUP-Home Depot, Palo Alto Networks, Wendys
U.S. RESEARCH ROUNDUP-Nvidia, Albemarle, Dropbox
10X Genomics Inc reports results for the quarter ended in December - Earnings Summary
Brief: 10X Genomics Q4 Revenue Growth 18%
10X Genomics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: 10x Genomics Expands Leadership In Single Cell Analysis With Launch Of GEM-X Technology